Citadel Advisors
NAUT icon

Citadel Advisors’s Nautilus Biotechnolgy NAUT Stock Holding History

Citadel Advisors’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.55M Buy
+1,896,192
New +$5.01M ﹤0.01% 5361
2025
Q4 		– Sell
-254,161
Closed -$215K – 13603
2025
Q3 		$215K Buy
254,161
+76,006
+43% +$55.9K ﹤0.01% 11119
2025
Q2 		$129K Buy
178,155
+75,227
+73% +$56.5K ﹤0.01% 11099
2025
Q1 		$88.6K Sell
102,928
-117,292
-53% -$174K ﹤0.01% 11636
2024
Q4 		$370K Buy
220,220
+140,881
+178% +$337K ﹤0.01% 9235
2024
Q3 		$226K Buy
79,339
+17,761
+29% +$46K ﹤0.01% 9896
2024
Q2 		$144K Buy
61,578
+5,953
+11% +$15.5K ﹤0.01% 10402
2024
Q1 		$164K Sell
55,625
-59,293
-52% -$168K ﹤0.01% 10634
2023
Q4 		$344K Buy
114,918
+107,860
+1,528% +$309K ﹤0.01% 8883
2023
Q3 		$22.3K Buy
7,058
+2,316
+49% +$7.54K ﹤0.01% 12539
2023
Q2 		$18.4K Buy
+4,742
New +$13.7K ﹤0.01% 12804
2022
Q4 		– Sell
-63,062
Closed -$134K – 15250
2022
Q3 		$134K Buy
63,062
+28,412
+82% +$71.5K ﹤0.01% 10829
2022
Q2 		$93K Sell
34,650
-23,815
-41% -$88.6K ﹤0.01% 11483
2022
Q1 		$254K Buy
58,465
+42,827
+274% +$176K ﹤0.01% 10964
2021
Q4 		$81K Sell
15,638
-21,254
-58% -$114K ﹤0.01% 12933
2021
Q3 		$226K Buy
+36,892
New +$294K ﹤0.01% 11712
2021
Q2 		– Sell
-302,610
Closed -$3.28M – 14135
2021
Q1 		$4.17M Buy
302,610
+2,610
+0.9% +$36.2K ﹤0.01% 4676
2020
Q4 		$3.25M Sell
300,000
-5,677
-2% -$59.8K ﹤0.01% 4453
2020
Q3 		$3.28M Buy
+305,677
New +$3.26M ﹤0.01% 3838

Other funds holding NAUT

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors's NAUT Position: Q2 2026 in Review

Citadel Advisors opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 1,896,192 shares worth $3.55M. The stake represents ﹤0.01% of the portfolio and ranks #5361 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NAUT as recently as Q3 2025.

Citadel Advisors first reported a position in NAUT in Q3 2020 and has held it in 19 quarters since. The position peaked at $4.17M in Q1 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Citadel Advisors held 1,896,192 shares of Nautilus Biotechnolgy worth $3.55M as of Q2 2026.
  • Nautilus Biotechnolgy was a new Citadel Advisors position in Q2 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5361 holding.
  • Citadel Advisors first reported a position in Nautilus Biotechnolgy in Q3 2020 and has held it in 19 quarters since.
  • Citadel Advisors's Nautilus Biotechnolgy position peaked at $4.17M in Q1 2021.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.